System Transmission

Top Signal

100#1 JOB

Activity

2180Ripe

+936 today

System

Livenow

Terminal Asset View

stockNASDAQ

VRAX

$0.19-2.55%

Virax Biolabs Group Ltd - Class A

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

23Overripe

Live Analysis Active

Company Mission

This company creates diagnostic tests to detect infectious diseases, such as COVID-19 and influenza. Healthcare providers and laboratories use these tests to diagnose patients quickly and accurately. It makes money by selling these tests and related services, generating revenue from medical and research customers.

VRA

Industry Context

This company operates in the biotechnology sector, focusing on infectious disease diagnostics. It develops tests that help detect viruses and other pathogens, which are used by hospitals, clinics, and research facilities. The demand for such products can fluctuate based on public health trends and outbreaks.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

73Matrix

Market Momentum

35.7— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.4x— Normal Volume

Today's Change

-2.55%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing VRAX across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:25 AM UTC

Develops diagnostic tests for infectious diseases like COVID-19 and flu, selling them to hospitals and labs to generate revenue.

No technical indicators available, but watch for price action near $0.19 as a key psychological level that could signal direction.

No volume data available, but monitor if volume spikes above average when news about disease outbreaks or regulatory approvals emerges.

No industry context available, but track if sector momentum in healthcare improves, as this could lift all biotech stocks.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...